Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea
Marie‐Laure Boof(Idorsia (Switzerland)), Mike Ufer(Idorsia (Switzerland)), Ingo Fietze(Humboldt-Universität zu Berlin), Jasper Dingemanse(Actelion (Switzerland)), Katharina Lederer(Charité - Universitätsmedizin Berlin)
Cited by 45
Related Papers
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Prevalence and association analysis of obstructive sleep apnea with gender and age differences – Results of SHIP‐Trend
|Journal of Sleep Research|2018|396
Non-CPAP therapies in obstructive sleep apnoea
|European Respiratory Journal|2011|379